Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Displays ; 2023.
Article in English | EuropePMC | ID: covidwho-2286123

ABSTRACT

Nucleic acid testing is currently the golden reference for coronaviruses (SARS-CoV-2) detection, while the SARS-CoV-2 antigen-detection rapid diagnostic tests (RDT) is an important adjunct. RDT can be widely used in the community or regional screening management as self-test tools and may need to be verified by healthcare authorities. However, manual verification of RDT results is a time-consuming task, and existing object detection algorithms usually suffer from high model complexity and computational effort, making them difficult to deploy. We propose LightR-YOLOv5, a compact rotating SARS-CoV-2 antigen-detection RDT results detector. Firstly, we employ an extremely light-weight L-ShuffleNetV2 network as a feature extraction network with a slight reduction in recognition accuracy. Secondly, we combine semantic and texture features in different layers by judiciously combining and employing GSConv, depth-wise convolution, and other modules, and further employ the NAM attention to locate the RDT result detection region. Furthermore, we propose a new data augmentation approach, Single-Copy-Paste, for increasing data samples for the specific task of RDT result detection while achieving a small improvement in model accuracy. Compared with some mainstream rotating object detection networks, the model size of our LightR-YOLOv5 is only 2.03MB, and it is 12.6%, 6.4%, and 7.3% higher in mAP@.5:.95 metrics compared to RetianNet, FCOS, and R3Det, respectively.

2.
Displays ; 78: 102403, 2023 Jul.
Article in English | MEDLINE | ID: covidwho-2286124

ABSTRACT

Nucleic acid testing is currently the golden reference for coronaviruses (SARS-CoV-2) detection, while the SARS-CoV-2 antigen-detection rapid diagnostic tests (RDT) is an important adjunct. RDT can be widely used in the community or regional screening management as self-test tools and may need to be verified by healthcare authorities. However, manual verification of RDT results is a time-consuming task, and existing object detection algorithms usually suffer from high model complexity and computational effort, making them difficult to deploy. We propose LightR-YOLOv5, a compact rotating SARS-CoV-2 antigen-detection RDT results detector. Firstly, we employ an extremely light-weight L-ShuffleNetV2 network as a feature extraction network with a slight reduction in recognition accuracy. Secondly, we combine semantic and texture features in different layers by judiciously combining and employing GSConv, depth-wise convolution, and other modules, and further employ the NAM attention to locate the RDT result detection region. Furthermore, we propose a new data augmentation approach, Single-Copy-Paste, for increasing data samples for the specific task of RDT result detection while achieving a small improvement in model accuracy. Compared with some mainstream rotating object detection networks, the model size of our LightR-YOLOv5 is only 2.03MB, and it is 12.6%, 6.4%, and 7.3% higher in mAP@.5:.95 metrics compared to RetianNet, FCOS, and R3Det, respectively.

3.
IEEE Trans Ultrason Ferroelectr Freq Control ; 68(7): 2507-2515, 2021 07.
Article in English | MEDLINE | ID: covidwho-1288239

ABSTRACT

As being radiation-free, portable, and capable of repetitive use, ultrasonography is playing an important role in diagnosing and evaluating the COVID-19 Pneumonia (PN) in this epidemic. By virtue of lung ultrasound scores (LUSS), lung ultrasound (LUS) was used to estimate the excessive lung fluid that is an important clinical manifestation of COVID-19 PN, with high sensitivity and specificity. However, as a qualitative method, LUSS suffered from large interobserver variations and requirement for experienced clinicians. Considering this limitation, we developed a quantitative and automatic lung ultrasound scoring system for evaluating the COVID-19 PN. A total of 1527 ultrasound images prospectively collected from 31 COVID-19 PN patients with different clinical conditions were evaluated and scored with LUSS by experienced clinicians. All images were processed via a series of computer-aided analysis, including curve-to-linear conversion, pleural line detection, region-of-interest (ROI) selection, and feature extraction. A collection of 28 features extracted from the ROI was specifically defined for mimicking the LUSS. Multilayer fully connected neural networks, support vector machines, and decision trees were developed for scoring LUS images using the fivefold cross validation. The model with 128×256 two fully connected layers gave the best accuracy of 87%. It is concluded that the proposed method could assess the ultrasound images by assigning LUSS automatically with high accuracy, potentially applicable to the clinics.


Subject(s)
COVID-19/diagnostic imaging , Image Interpretation, Computer-Assisted/methods , Lung/diagnostic imaging , Neural Networks, Computer , Ultrasonography/methods , Adult , Aged , Female , Humans , Male , Middle Aged , SARS-CoV-2
4.
IEEE Sens J ; 21(9): 11084-11093, 2021 May 01.
Article in English | MEDLINE | ID: covidwho-1132775

ABSTRACT

Coronavirus Disease 2019 (COVID-19) has spread all over the world since it broke out massively in December 2019, which has caused a large loss to the whole world. Both the confirmed cases and death cases have reached a relatively frightening number. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19, can be transmitted by small respiratory droplets. To curb its spread at the source, wearing masks is a convenient and effective measure. In most cases, people use face masks in a high-frequent but short-time way. Aimed at solving the problem that we do not know which service stage of the mask belongs to, we propose a detection system based on the mobile phone. We first extract four features from the gray level co-occurrence matrixes (GLCMs) of the face mask's micro-photos. Next, a three-result detection system is accomplished by using K Nearest Neighbor (KNN) algorithm. The results of validation experiments show that our system can reach an accuracy of 82.87% (measured by macro-measures) on the testing dataset. The precision of Type I 'normal use' and the recall of type III 'not recommended' reach 92.00% and 92.59%. In future work, we plan to expand the detection objects to more mask types. This work demonstrates that the proposed mobile microscope system can be used as an assistant for face mask being used, which may play a positive role in fighting against COVID-19.

5.
Ieee Sensors Journal ; 20(22):13674-13681, 2020.
Article | Web of Science | ID: covidwho-907569

ABSTRACT

Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronaviruses 2 (SARS-CoV-2) has become a serious global pandemic in the past few months and caused huge loss to human society worldwide. For such a large-scale pandemic, early detection and isolation of potential virus carriers is essential to curb the spread of the pandemic. Recent studies have shown that one important feature of COVID-19 is the abnormal respiratory status caused by viral infections. During the pandemic, many people tend to wear masks to reduce the risk of getting sick. Therefore, in this paper, we propose a portable non-contact method to screen the health conditions of people wearing masks through analysis of the respiratory characteristics from RGB-infrared sensors. We first accomplish a respiratory data capture technique for people wearing masks by using face recognition. Then, a bidirectional GRU neural network with an attention mechanism is applied to the respiratory data to obtain the health screening result. The results of validation experiments show that our model can identify the health status of respiratory with 83.69% accuracy, 90.23% sensitivity and 76.31% specificity on the real-world dataset. This work demonstrates that the proposed RGB-infrared sensors on portable device can be used as a pre-scan method for respiratory infections, which provides a theoretical basis to encourage controlled clinical trials and thus helps fight the current COVID-19 pandemic. The demo videos of the proposed system are available at: https://doi.org/10.6084/m9.figshare.12028032.

SELECTION OF CITATIONS
SEARCH DETAIL